Ailing AstraZeneca to cut one in 10 jobs
LONDON (Reuters) - AstraZeneca's new chief executive announced another 2,300 job cuts in sales and administration on Thursday as he set out his stall for turning round the struggling drugmaker...
Home > Reviews
All Stories
As ‘telehealth’ grows, experts question cost benefits
LONDON (Reuters) - Monitoring patients at home using modern technology, so-called 'telehealth', is tipped as the next big thing in healthcare, but a new study by British researchers suggests it...
As ‘telehealth’ grows, experts question cost benefits
LONDON (Reuters) - Monitoring patients at home using modern technology, so-called 'telehealth', is tipped as the next big thing in healthcare, but a new study by British researchers suggests it...
Ailing AstraZeneca to cut one in 10 jobs
LONDON (Reuters) - AstraZeneca's new chief executive announced another 2,300 job cuts in sales and administration on Thursday as he set out his stall for turning round the struggling drugmaker...
Big pharma: Few new antibiotics in the works
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as...
Big pharma: Few new antibiotics in the works
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as...
Analysis: Antibiotics crisis prompts rethink on risks, rewards
LONDON (Reuters) - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new...
Analysis: Antibiotics crisis prompts rethink on risks, rewards
LONDON (Reuters) - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new...
Tapeworm genome points way to better drug treatments
LONDON (Reuters) - Scientists have for the first time mapped the genomes of tapeworms, shedding light on the evolution of one of humankind's oldest parasites and revealing new possibilities for...
Tapeworm genome points way to better drug treatments
LONDON (Reuters) - Scientists have for the first time mapped the genomes of tapeworms, shedding light on the evolution of one of humankind's oldest parasites and revealing new possibilities for...